"In June of 2010, the AIDS Treatment Activist Coalition (ATAC) and European AIDS Trials Group (EATG) sent an open letter to Susan Cox, PhD, Chief Scientific Officer of Avexa, Nathan Droma, Chair of Avexa and Stephen Kerr, the Company’s Board Secretary that was published on TheBody.com requesting that Avexa reconsider their decision to stop the development of ATC due to the critical need for this drug. "
http://www.hivplusmag.com/research/...itive-people-need-hiv-drug-still-not-approved
I find this very interesting reading
- Forums
- ASX - By Stock
- AVX
- Ann: ATC listed as important option for HIV sufferers
Ann: ATC listed as important option for HIV sufferers, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online